Last reviewed · How we verify
NCT05750342: PERSOB
Clinical Trial to Analyze the Efficacy of a Supplement Extracted From Persimmon on Overweight / Obesity.
NA trial testing Experimental Product Caqui in Supplementation in 80 participants. Completed in 6 May 2024.
28 March 2024
Quick facts
| Lead sponsor | Universidad Católica San Antonio de Murcia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 80 |
| Start date | 1 February 2023 |
| Primary completion | 28 March 2024 |
| Estimated completion | 6 May 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Experimental Product Caqui
- Control product placebo
Conditions studied
- Supplementation — all drugs for Supplementation →
- Obesity — all drugs for Obesity →
Sponsor
Universidad Católica San Antonio de Murcia
Who can join
Adults 18 to 65, any sex, with Supplementation or Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Randomized, controlled, double-blind clinical trial, with two parallel branches depending on the product consumed (experimental product and placebo product) and single-center, to measure the efficacy of a supplement extracted from Persimmon on overweight and obesity grade I in subjects with BMI over 25.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Efficacy of a Dietary Supplement Extracted from Persimmon (<i>Diospyros kaki</i> L.f.) in Overweight Healthy Adults: A Randomized, Double-Blind, Controlled Clinical Trial.
Pérez-Piñero S, Muñoz-Carrillo JC, Echepare-Taberna J, Herrera-Fernández C, et al · · 2024 · PMID 39767014 · DOI 10.3390/foods13244072
Verify or expand the search:
- PubMed search for NCT05750342
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Supplementation
Currently open trials in the same condition.
- NCT07504068 — Effects of Physical Exercise and a Nutritional Supplement on Body Composition, Metabolic Function, and Overall Health in · NA · recruiting
- NCT07252778 — Effect of a Short-term Multi-strain Probiotic Supplementation in Endurance Athletes · Phase 2, PHASE3 · recruiting
- NCT07213063 — Effects of Chronic Creatine and Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Oxidative Stress, Inflammation, Musc · NA · recruiting
- NCT05878106 — Creatine Supplementation and Resistance Training in Patients With Breast Cancer · NA · recruiting
- NCT05516212 — Caffeine Kinetics and CrossFit®-Specific Performance · Phase 2, PHASE3 · recruiting
Other Universidad Católica San Antonio de Murcia trials
Trials by the same sponsor.
- NCT07397910 — Clinical Trial on a Natural Compound to Improve Chronic Inflammation After SARS-CoV-2 Infection · NA · not yet recruiting
- NCT07519980 — Xanthigen and Its Impact on Weight and Metabolic Health · NA · recruiting
- NCT07391189 — Healthy Effects of Adapted Aikido in People With Grip Disfunction · NA · recruiting
- NCT07379931 — Evaluating a Liquid Extract of Carob to Improve Blood Sugar in People With Prediabetes · NA · not yet recruiting
- NCT07488000 — Plyometric Exercises During the Winter Pre-season in Sprinters · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05750342 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Católica San Antonio de Murcia
- Last refreshed: 17 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05750342.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing